Skip to main content
. 2016 Mar 9;10(9):1033–1041. doi: 10.1093/ecco-jcc/jjw060

Figure 4.

Figure 4.

Factors affecting the effectiveness of adalimumab identified by multiple logistic regression with as-observed analysis [patients were considered responders if they showed a response at 24 weeks]. a p-value was calculated using Wald’s chi-square test. CI, confidence interval; CDAI, Crohn’s Disease Activity Index; OR, odds ratio; TNFα, tumour necrosis factor alpha.